companydata.dkcompanydata.dk

Signum Life Science ApS: Financial statements 2021

CVR: 36559241

Source: annual report 2021, Danish Business Authority

01/01/2021 – 31/12/2021

Signum Life Science ApS (CVR 36559241) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK 7,602,418 and a net result of DKK 1,317,024 compared with DKK 1,046,195 the year before. That is a decrease of 6.1% compared with the year before. Equity in the 2021 report amounted to DKK 128,462,822. The solvency ratio was 85.1%. The company had 34 employees in the financial year.

Gross Profit
DKK 7,602,418
Profit/Loss
DKK 1,317,024
Equity
DKK 128,462,822
Total Assets
DKK 150,969,926
Employees
34

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2021-7.6M1.3M128.5M34
2020-8.1M1M128.2M32
2019-10.5M3.8M129.2M28
2018-12M4.1M127.5M21
2017-12.5M5.5M125.8M-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Find more companies like Signum Life Science ApS

Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.

Try the lead list generator

Events in 2021

Signum Life Science ApS: The 2020 annual report is outMay 26, 2021

Signum Life Science ApS has published its annual report for 2020. Gross profit came to DKK 8,099,776, and the net result was DKK 1,046,195.

Tore von Würden Petersen joins the board of Signum Life Science ApSApr 8, 2021

As of April 8, 2021, Tore von Würden Petersen has joined the board of directors of Signum Life Science ApS.

Andreas Daugaard Jørgensen leaves the board of Signum Life Science ApSFeb 1, 2021

As of February 1, 2021, Andreas Daugaard Jørgensen has left the board of directors of Signum Life Science ApS.

About Signum Life Science ApS

Signum Life Science ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2015. The company is registered under the industry Computerkonsulentbistand og forvaltning af computerfaciliteter. The company was previously named DLI Market Intelligence ApS. The management consists of Thomas Senderovitz. The board consists of Anja Cecilie Verhaug (chair), Mari-Ann Retz, Anne Marie Hedegaard Byskov and Søren Hvidsten Nielsen. The company is owned by DLI - DANSK LÆGEMIDDEL INFORMATION A/S and TJELLESEN MAX JENNE A/S. The company has 53 employees (2026). In 2025, the company reported a gross profit of DKK -67,441,461 and a net result of DKK -66,049,966 compared with DKK -5,936,982 the year before. Equity in the 2025 report amounted to DKK 40,680,589.

Source: annual report 2025, Danish Business Authority